×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Bhuvnesh Singh
Bhuvnesh Singh
Nifty stocks well-owned; like pharma, paint cos: Barclays
Q2FY16 earnings lacklustre, downgrade industrials: Barclays
Nifty may move to 9642, Maruti, SBI top picks: Barclays
Optimistic on consumption recovery in H2FY16: Barclays
Optimistic on earnings revival in H2FY16, buy SBI: Barclays
Slow earnings revival scary: Analysts cut market target
See further downside till 8000 on Nifty in near term: Ambit
Nifty target at 10,200; earnings to sprint in H2: Barclays
Mar quarter earnings season starts on muted note: Barclays
Expect inflation to stay low, rate cut hopes rise: Barclays
Capex cycle in India unlikely to recover quickly: Barclays
Earnings momentum needs to sustain ROE in India: Barclays
JPMorgan sees 8-10% potential upside in market by FY15-end
ICICI, Hindalco, Reliance are Election picks: Barclays
Interact with CNBC-TV18: Bhuvnesh Singh bullish on IT, pharma post Q3 earnings
Prefer pharma, IT services space: Bhuvnesh Singh
Nifty to trade around 6500 over next 12 months: Barclays
FIIs being overweight is a risk for market: Barclays Cap
RBI's move may negatively impact capex, earnings: Barclays
US recovery may strengthen dollar: CLSA
Barclays Cap says FIIs bullish on India; gives stock ideas
High-yield stocks remain relatively attractive, says HSBC
5564 should be seen as attractive buying opportunity: CLSA
Underweight on financials: Barclays
Expect Nifty to range between 5050-6100: Barclays
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio